Mucosal vaccination against bacterial respiratory infections

被引：26

作者：

Baumann, Ulrich ^{[1
]}

机构：

[1] Hannover Med Sch, Dept Pediat Pulmonol & Neonatol, Immunol Unit, D-30625 Hannover, Germany

来源：

EXPERT REVIEW OF VACCINES | 2008年 / 7卷 / 08期

关键词：

adjuvant; Bordetella pertussis; Haemophilus influenzae; Moraxella catarrhalis; mucosa-associated lymphoid tissue; mucosal vaccination; Mycobacterium tuberculosis; nasal vaccination; oral vaccination; Pseudomonas aeroginosa; respiratory infection; Streptococcus pneumoniae;

D O I：

10.1586/14760584.7.8.1257

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Mucosal vaccination offers attractive advantages to conventional systemic vaccination, such as higher levels of antibodies and protection at the airway surface. This review gives an overview of recent experimental and clinical data on nasal, oral and sublingual vaccines against bacterial respiratory pathogens, such as Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, Moraxella catarrhalis, Bordetella pertussis, Pseudomonas aeruginosa and Mycobacterium tuberculosis. Subsequently, we discuss further vaccine development that opens the focus to clinical use.

引用

页码：1257 / 1276

页数：20

共 144 条

[1] Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against nontypeable Haemophilus influenzae in the nasopharynx [J].

Abe, N ;

Kodama, S ;

Hirano, T ;

Eto, M ;

Suzuki, M .

LARYNGOSCOPE, 2006, 116 (03) :407-412

[2] INTRANASAL IMMUNIZATION WITH BACTERIAL POLYSACCHARIDE CONTAINING LIPOSOMES ENHANCES ANTIGEN-SPECIFIC PULMONARY SECRETORY ANTIBODY-RESPONSE [J].

ABRAHAM, E .

VACCINE, 1992, 10 (07) :461-468

[3] Production of nontypeable Haemophilus influenzae HtrA by recombinant Bordetella pertussis with the use of filamentous hemagglutinin as a carrier [J].

Alonso, S ;

Willery, E ;

Renauld-Mongénie, G ;

Locht, C .

INFECTION AND IMMUNITY, 2005, 73 (07) :4295-4301

[4] The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis [J].

Andersen, Claire Swetman ;

Dietrich, Jes ;

Agger, Else Marie ;

Lycke, Nils Y. ;

Lovgren, Karin ;

Andersen, Peter .

INFECTION AND IMMUNITY, 2007, 75 (01) :408-416

[5] Expression and characterization of cholera toxin B -: pneumococcal surface adhesin A fusion protein in Escherichia coli:: ability of CTB-PsaA to induce humoral immune response in mice [J].

Areas, APM ;

Oliveira, MLS ;

Miyaji, EN ;

Leite, LCC ;

Aires, KA ;

Dias, WO ;

Ho, PL .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 321 (01) :192-196

[6] Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa [J].

Arnold, H ;

Bumann, D ;

Felies, M ;

Gewecke, B ;

Sörensen, M ;

Gessner, JE ;

Freihorst, J ;

von Specht, BU ;

Baumann, U .

INFECTION AND IMMUNITY, 2004, 72 (11) :6546-6553

[7] Development of lactococcal GEM-based pneumococcal vaccines [J].

Audouy, Sandrine A. L. ;

van Selm, Saskia ;

van Roosmalen, Maarten L. ;

Post, Eduard ;

Kanninga, Rolf ;

Neef, Jolanda ;

Estevao, Silvia ;

Nieuwenhuis, Edward E. S. ;

Adrian, Peter V. ;

Leenhouts, Kees ;

Hermans, Peter W. M. .

VACCINE, 2007, 25 (13) :2497-2506

[8] Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization [J].

Audouy, Sandrine A. L. ;

van Roosmalen, Maarten L. ;

Neef, Jolanda ;

Kanninga, Rolf ;

Post, Eduard ;

van Deemter, Marielle ;

Metselaar, Heidi ;

van Selm, Saskia ;

Robillard, George T. ;

Leenhouts, Kees J. ;

Hermans, Peter W. M. .

VACCINE, 2006, 24 (26) :5434-5441

[9] Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles [J].

Baudner, BC ;

Balland, O ;

Giuliani, MM ;

Von Hoegen, P ;

Rappuoli, R ;

Betbeder, D ;

Del Giudice, G .

INFECTION AND IMMUNITY, 2002, 70 (09) :4785-4790

[10] Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform [J].

Baudner, BC ;

Verhoef, JC ;

Giuliani, MM ;

Peppoloni, S ;

Rappuoli, R ;

Del Giudice, G ;

Junginger, HE .

JOURNAL OF DRUG TARGETING, 2005, 13 (8-9) :489-498

← 1 2 3 4 5 6 7 8 9 10 →